The bone marrow microenvironment influences the differential chemokine receptor expression of normal and neoplastic plasma cells [4]

Blood

Volumn 105, Issue 12, 2005, Pages 4895-4896

  Al Rayes, Mona H ^b   Rawstron, Andy C ^b   Morgan, Gareth J ^b   Davies, Faith E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPHYCOCYANIN; CD19 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYANINE DYE; FLUORESCEIN ISOTHIOCYANATE; PHYCOERYTHRIN; SYNDECAN 1;

B LYMPHOCYTE; BONE MARROW; CELL DIFFERENTIATION; CELL TRANSFORMATION; COMPARATIVE STUDY; FLOW CYTOMETRY; HUMAN; LETTER; MICROENVIRONMENT; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA CELL; NEOPLASM; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 20444369193     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-10-3840     Document Type: Letter

References (9)

1. Rawstron AC, Davies FE, DasGupta R, et al. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic PCs predicts outcome after transplantation. Blood. 2002;100:3095-3100.
2. Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of PCs from monoclonal gammopathy of undetermined significance patients: implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol. 1998;152:1655-1665.
3. Rawstron AC, Fenton JAL, Gonzalez D, et al. High-risk MGUS: identification by immunophenotype, karyotype, and clonal homogeneity [abstract 116]. Blood. 2003;102:36.
4. Rawstron AC, Fenton JA, Ashcroft J, et al. The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal PCs. Blood. 2000;96:3880-3886.
5. Hargreaves DC, Hyman PL, Lu T, et al. A coordinated change in chemokine responsiveness guides PC movement. J Exp Med. 2001;194:45-56.
6. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human PCs accounts for their efficient recruitment to target tissues. J Immunol. 2003;170:1136-1140.
7. Broek IV, Asosingh K, Vanderkerken K, Straetmans N, Van Camp B, Van Riet I. Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and 3. Br J Cancer. 2003;88:855-862.
8. Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia. 2001;15:752-756.
9. Moller C, Stromberg T, Turemalm M, Nilsson K, Nilsson G. Expression and function of chemokine receptors in human multiple myeloma. Leukemia. 2003;17:203-210.